NAFLD referral patterns in a large US academic center

We read with interest the manuscript by Srivastava et  al.1 We are excited to hear of a novel pathway to capture patients with non-alcoholic fatty liver disease (NAFLD) and advanced fibrosis or cirrhosis using sequential non-invasive scoring systems. With the development of agents to potentially reverse NAFLD fibrosis, there is a significant need to i mprove screening of at-risk populations and develop mechanisms for early effective linkage-to-care. Srivastava et al. shed light on the scale of the problem when it comes to screening in the UK, but data from the US remain limited.

Source: Journal of Hepatology - May 11, 2020 Category: Gastroenterology Authors: Marcia Leung, Cindy Piao, Souvik Sarkar Tags: Letter to the Editor Source Type: research